ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Continuous drug production advances

by Ann M. Thayer
March 14, 2016 | APPEARED IN VOLUME 94, ISSUE 11

The pharma services firm Hovione will operate a commercial-scale continuous manufacturing facility to make finished drugs for Vertex Pharmaceuticals. The agreement adds to a $24 million project to double capacity at Hovione’s site in East Windsor, N.J. When completed by the end of 2017, the new facility will link all the steps to produce tableted drugs: blending, wet or dry granulation, fluid bed drying, tableting, coating, and real-time release testing. Hovione will offer any spare capacity to other clients.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment